comparemela.com
Home
Live Updates
Questor: this medical stock is expensive – but worth paying for : comparemela.com
Questor: this medical stock is expensive – but worth paying for
It’s a stock market rule of thumb that big acquisitions tend to destroy shareholder value. Spin-offs, on the other hand, have the reassuring habit of being more likely to create it.
Related Keywords
Switzerland
,
Swiss
,
Alistair Wittet
,
Citywire Elite Companies
,
Novartis
,
Comgest Growth Europe
,
Falcon
,
Eye Operations
,
Shareholder Value
,
Citywire
,
Stock Market
,
comparemela.com © 2020. All Rights Reserved.